PVRIG Is a Novel Natural Killer Cell Immune Checkpoint Receptor in Acute Myeloid Leukemia

PVRIG blockade significantly enhanced NK-cell killing of poliovirus receptor-related 2 (PVRL2)+, poliovirus receptorlo AML cell lines, and significantly increased NK-cell activation and degranulation in the context of patient primary AML blasts.